Benzquinamide
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Trade names | Promecon, Quantril, Emete-Con |
License data | |
Routes of administration |
Suppository, injection |
ATC code | none |
Identifiers | |
|
|
CAS Number | 63-12-7 |
IUPHAR/BPS | 7124 |
DrugBank | DB00767 |
ChemSpider | 2252 |
UNII | 0475EA27Q3 |
KEGG | D00243 |
ChEMBL | CHEMBL1201250 |
Chemical and physical data | |
Formula | C22H32N2O5 |
Molar mass | 404.5 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[1] [2]
References[edit]
- ^ Scriabine A, Weissman A, Finger KF (1963). "Benzquinamide". JAMA. 184 (4): 276. doi:10.1001/jama.1963.73700170001010. ISSN 0098-7484.
- ^ E.I. Goldenthal (1971). "A compilation of LD50 values in newborn and adult animals". Toxicol. Appl. Pharmacol. 18 (1): 185–207. doi:10.1016/0041-008X(71)90328-0. PMID 5542824.
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |